Confused about which vaccines somebody is talking about? I don’t blame you.
| Manufacturer | Research names (Amount) | Trade name | Variant |
| Pfizer/BioNTech | BNT162b2 (30 µg) / tozinameran | Comirnaty | Classic |
| Pfizer/BioNTech | BNT162b2 OMI (30 µg) | ? | BA.1 |
| Pfizer/BioNTech | BNT162b2 Bivalent (WT/OMI BA.4/BA.5)(30 µg) | ? | Bivalent BA.4/5 |
| Moderna | mRNA-1273 (100 µg) | Spikevax | Classic |
| Moderna | mRNA-1273.529 | Spikevax | BA.1 |
| Moderna | mRNA-1273.045 | Spikevax | BA.4/5 |
| Moderna | mRNA-1273.211 (50 µg) | Spikevax | Classic + Beta |
| Moderna | mRNA-1273.214 (50 µg) | Spikevax | Classic + BA.1 |
| Moderna | mRNA-1273.222 (50 µg) | Spikevax | Classic + BA.5 |
| Moderna | mRNA-1273.351 (50 µg) | Spikevax | Beta |
| Moderna | mRNA-1273.815 (50 µg) | Spikevax | XBB.1.5 |
| Moderna | mRNA-1273.231 (50 µg) | Spikevax | BA.5 + XBB.1.5 |
| Moderna | mRNA1283.222 (10 µg) | mNexspike | Classic + BA.5 |
| AstraZeneca | AZD1222 / ChAdOx1 | Vaxzevria | Classic |
| Johnson&Johnson | JNJ-78436735 / Ad26.COV2.S / VAC31518 / Ad26COVS1 | Janssen COVID-19 Vaccine | Classic |
| Bharat Biotech | BBV152 | Covaxin | Classic |
| Bharat Biotech | BBV154 (nasal) | iNCOVACC | ? |
| Novavax | NVX-CoV2373 (5 µg regular + 50 µg adjuvant, 5 µg booster [active ingredient or total?]) | Nuvaxovid | Classic |
| Novavax | NVX-CoV2515 | ? | BA.1 |
| Serum Institute of India | NVX-CoV2373 | Covovax | Classic |
| Clover | SCB-2019 | not yet | I’m not sure |
| Serum Institute of India | AZD1222 / ChAdOx1 | Covishield | Classic |
| Biological E | Corbevax? | Corbevax | Classic |
| Vietnam | NDV-HXP-S / HexaPro | Covivac | Classic |
| Avimex (Mexico) | NDV-HXP-S / HexaPro | Patria | Classic |
| Butantan Institute (Brazil) | NDV-HXP-S / HexaPro | Butanvax or ADAPTCOV | Classic |
| Mahidol University / Government Pharmaceutical Organization (Thailand) | NDV-HXP-S / HexaPro | HXP-GPOVac | Classic |
| Institute of Vaccines and Medical Biologicals (Vietnam) | NDV-HXP-S / HexaPro | COVIVAC | Classic |
| Sanofi/GSK | dTM-AS03 / VAT08 | VidPrevtyn Beta | Beta |
| Medicago | CoVLP | Covifenz | Classic |
| Gennova | ? | GEMCOVAC-19 | Classic |
| SK Chemicals/University of Washington | GBP510 | SKYCovione | Classic |
| Medigen | MVC-COV1901 | Classic | |
| Shionogi (protein subunit) | S-268019 | ||
| CanSino | CS-2034 | ? | |
| Sinovac Biotech | Ad5-nCoV | CoronaVac | ? |
| SinoCellTech | SCTV01C | Omicron | |
| Wantai BioPharm | nasal spray | VectorFlu ONE | ? |
| WestVac Biopharms | Sf9 | ? | |
| HIPRA | PHH-1V | BIMERVAX | Alpha and Beta |
| HIPRA | PHH-1V81 | ? | XBB.1.16 |
Note: the company that developed the vaccine is not always the same as the one which manufactures it.
- Comirnaty is manufactured by Pfizer under license from BioNTech.
- Covishield is manufactured by SII under license from AstraZeneca.
- Covovax is manufactured by SII under license from Novavax.
- Corbevax is manufactured by Biological E under (free) license from Texas Children’s Hospital.
- The NDV-HXP-S vaccines are made under (free) license from the University of Texas at Austin (which developed the 6-proline stabilization) and the Icahn School of Medicine at Mount Sinai (which did everything else).
- Novavax has their own manufacturing and also licensed the vax to Serum Institute of India. They had had problems with manufacturing, so I think that as of Feb 2022, most (all?) of the Novavax that is sold is from SII.
- GEMCOVAC-19’s situation is messy. A Seattle company named HDT Bio licensed its self-amplifying technology to Gennova; Gennova was going to manufacture it worldwide and had exclusive rights to the Indian market, but HDT Bio has sued, saying that Gennova filed patent claims on HDT Bio’s technology.